VRC-MARDNA025-00-VP (NIH)

N/A

Report date: 2022/12/26 12:27:33

Base Information

Drug NameVRC-MARDNA025-00-VP (NIH)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMarburg Virus Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)National Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsMarburg Virus Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A